nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—ovarian cancer—polycystic ovary syndrome	0.548	1	CtDrD
Docetaxel—BCL2—polycystic ovary syndrome	0.273	1	CbGaD
Docetaxel—Angina unstable—Metformin—polycystic ovary syndrome	0.00315	0.0893	CcSEcCtD
Docetaxel—Reaction gastrointestinal—Metformin—polycystic ovary syndrome	0.00239	0.0676	CcSEcCtD
Docetaxel—KIF11—embryo—polycystic ovary syndrome	0.00231	0.0375	CbGeAlD
Docetaxel—GHRHR—pituitary gland—polycystic ovary syndrome	0.0018	0.0292	CbGeAlD
Docetaxel—KIF11—endometrium—polycystic ovary syndrome	0.00169	0.0275	CbGeAlD
Docetaxel—Paclitaxel—BCL2—polycystic ovary syndrome	0.0014	0.663	CrCbGaD
Docetaxel—GHRHR—endocrine gland—polycystic ovary syndrome	0.00139	0.0226	CbGeAlD
Docetaxel—KIF11—adrenal gland—polycystic ovary syndrome	0.00137	0.0222	CbGeAlD
Docetaxel—KIF11—female gonad—polycystic ovary syndrome	0.00128	0.0207	CbGeAlD
Docetaxel—KIF11—vagina—polycystic ovary syndrome	0.00127	0.0206	CbGeAlD
Docetaxel—Nail disorder—Metformin—polycystic ovary syndrome	0.00123	0.0348	CcSEcCtD
Docetaxel—Heartburn—Metformin—polycystic ovary syndrome	0.00116	0.0328	CcSEcCtD
Docetaxel—MAP4—embryo—polycystic ovary syndrome	0.00107	0.0173	CbGeAlD
Docetaxel—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.000984	0.0278	CcSEcCtD
Docetaxel—Rigors—Metformin—polycystic ovary syndrome	0.000976	0.0276	CcSEcCtD
Docetaxel—Chest discomfort—Metformin—polycystic ovary syndrome	0.000901	0.0255	CcSEcCtD
Docetaxel—MAPT—pituitary gland—polycystic ovary syndrome	0.000898	0.0146	CbGeAlD
Docetaxel—MAPT—adipose tissue—polycystic ovary syndrome	0.000894	0.0145	CbGeAlD
Docetaxel—MAP2—embryo—polycystic ovary syndrome	0.000839	0.0136	CbGeAlD
Docetaxel—NR1I2—endocrine gland—polycystic ovary syndrome	0.000836	0.0136	CbGeAlD
Docetaxel—MAPT—adrenal gland—polycystic ovary syndrome	0.000802	0.013	CbGeAlD
Docetaxel—Neuropathy—Metformin—polycystic ovary syndrome	0.000748	0.0212	CcSEcCtD
Docetaxel—MAP4—uterus—polycystic ovary syndrome	0.000719	0.0117	CbGeAlD
Docetaxel—Lightheadedness—Metformin—polycystic ovary syndrome	0.000713	0.0202	CcSEcCtD
Docetaxel—Paclitaxel—CYP19A1—polycystic ovary syndrome	0.000711	0.337	CrCbGaD
Docetaxel—BCL2—endometrium—polycystic ovary syndrome	0.000709	0.0115	CbGeAlD
Docetaxel—MAP4—adipose tissue—polycystic ovary syndrome	0.000703	0.0114	CbGeAlD
Docetaxel—MAP2—adrenal cortex—polycystic ovary syndrome	0.000688	0.0112	CbGeAlD
Docetaxel—TUBB1—adipose tissue—polycystic ovary syndrome	0.000687	0.0112	CbGeAlD
Docetaxel—BCL2—uterus—polycystic ovary syndrome	0.000653	0.0106	CbGeAlD
Docetaxel—TUBB4A—embryo—polycystic ovary syndrome	0.000649	0.0105	CbGeAlD
Docetaxel—EGFR—uterus—polycystic ovary syndrome	0.000646	0.0105	CbGeAlD
Docetaxel—CYP3A4—urine—polycystic ovary syndrome	0.000643	0.0104	CbGeAlD
Docetaxel—EGFR—adipose tissue—polycystic ovary syndrome	0.000631	0.0102	CbGeAlD
Docetaxel—MAP4—adrenal gland—polycystic ovary syndrome	0.00063	0.0102	CbGeAlD
Docetaxel—SLCO1B3—pituitary gland—polycystic ovary syndrome	0.000618	0.01	CbGeAlD
Docetaxel—MAP2—endometrium—polycystic ovary syndrome	0.000614	0.00997	CbGeAlD
Docetaxel—Renal impairment—Metformin—polycystic ovary syndrome	0.000608	0.0172	CcSEcCtD
Docetaxel—Lethargy—Metformin—polycystic ovary syndrome	0.00059	0.0167	CcSEcCtD
Docetaxel—MAP4—female gonad—polycystic ovary syndrome	0.000588	0.00954	CbGeAlD
Docetaxel—MAP4—vagina—polycystic ovary syndrome	0.000584	0.00948	CbGeAlD
Docetaxel—Pain in extremity—Metformin—polycystic ovary syndrome	0.000578	0.0164	CcSEcCtD
Docetaxel—Migraine—Metformin—polycystic ovary syndrome	0.000569	0.0161	CcSEcCtD
Docetaxel—EGFR—adrenal gland—polycystic ovary syndrome	0.000566	0.00919	CbGeAlD
Docetaxel—MAP2—pituitary gland—polycystic ovary syndrome	0.000556	0.00902	CbGeAlD
Docetaxel—MAP2—adipose tissue—polycystic ovary syndrome	0.000553	0.00898	CbGeAlD
Docetaxel—MAP4—endocrine gland—polycystic ovary syndrome	0.000547	0.00887	CbGeAlD
Docetaxel—Dehydration—Metformin—polycystic ovary syndrome	0.000538	0.0152	CcSEcCtD
Docetaxel—BCL2—female gonad—polycystic ovary syndrome	0.000534	0.00867	CbGeAlD
Docetaxel—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000534	0.0151	CcSEcCtD
Docetaxel—TUBB4A—adrenal cortex—polycystic ovary syndrome	0.000531	0.00863	CbGeAlD
Docetaxel—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000528	0.015	CcSEcCtD
Docetaxel—EGFR—female gonad—polycystic ovary syndrome	0.000528	0.00857	CbGeAlD
Docetaxel—Breast disorder—Metformin—polycystic ovary syndrome	0.000523	0.0148	CcSEcCtD
Docetaxel—Cramp muscle—Metformin—polycystic ovary syndrome	0.000521	0.0147	CcSEcCtD
Docetaxel—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000517	0.0146	CcSEcCtD
Docetaxel—SLCO1B3—vagina—polycystic ovary syndrome	0.000512	0.0083	CbGeAlD
Docetaxel—TUBB4B—embryo—polycystic ovary syndrome	0.000506	0.00821	CbGeAlD
Docetaxel—BCL2—endocrine gland—polycystic ovary syndrome	0.000497	0.00807	CbGeAlD
Docetaxel—MAP2—adrenal gland—polycystic ovary syndrome	0.000496	0.00806	CbGeAlD
Docetaxel—Angina pectoris—Metformin—polycystic ovary syndrome	0.000487	0.0138	CcSEcCtD
Docetaxel—TUBB—adrenal cortex—polycystic ovary syndrome	0.000486	0.00789	CbGeAlD
Docetaxel—TUBB2A—adrenal cortex—polycystic ovary syndrome	0.000484	0.00785	CbGeAlD
Docetaxel—SLCO1B3—endocrine gland—polycystic ovary syndrome	0.000479	0.00777	CbGeAlD
Docetaxel—TUBB6—adrenal cortex—polycystic ovary syndrome	0.000477	0.00774	CbGeAlD
Docetaxel—Neutropenia—Metformin—polycystic ovary syndrome	0.000468	0.0132	CcSEcCtD
Docetaxel—MAP2—female gonad—polycystic ovary syndrome	0.000463	0.00751	CbGeAlD
Docetaxel—MAP2—vagina—polycystic ovary syndrome	0.00046	0.00747	CbGeAlD
Docetaxel—TUBB2B—endometrium—polycystic ovary syndrome	0.000459	0.00744	CbGeAlD
Docetaxel—Infestation NOS—Metformin—polycystic ovary syndrome	0.000446	0.0126	CcSEcCtD
Docetaxel—Infestation—Metformin—polycystic ovary syndrome	0.000446	0.0126	CcSEcCtD
Docetaxel—TUBB4A—uterus—polycystic ovary syndrome	0.000437	0.0071	CbGeAlD
Docetaxel—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000437	0.0124	CcSEcCtD
Docetaxel—TUBB—endometrium—polycystic ovary syndrome	0.000434	0.00704	CbGeAlD
Docetaxel—TUBB2A—endometrium—polycystic ovary syndrome	0.000432	0.00701	CbGeAlD
Docetaxel—MAP2—endocrine gland—polycystic ovary syndrome	0.000431	0.00699	CbGeAlD
Docetaxel—TUBB6—endometrium—polycystic ovary syndrome	0.000426	0.00691	CbGeAlD
Docetaxel—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000422	0.0119	CcSEcCtD
Docetaxel—ABCC10—adrenal cortex—polycystic ovary syndrome	0.000418	0.00678	CbGeAlD
Docetaxel—TUBB2B—pituitary gland—polycystic ovary syndrome	0.000415	0.00674	CbGeAlD
Docetaxel—TUBB4B—adrenal cortex—polycystic ovary syndrome	0.000415	0.00673	CbGeAlD
Docetaxel—TUBB2B—adipose tissue—polycystic ovary syndrome	0.000413	0.00671	CbGeAlD
Docetaxel—CYP3A7—endocrine gland—polycystic ovary syndrome	0.000404	0.00655	CbGeAlD
Docetaxel—Rhinitis—Metformin—polycystic ovary syndrome	0.000401	0.0114	CcSEcCtD
Docetaxel—Hepatitis—Metformin—polycystic ovary syndrome	0.0004	0.0113	CcSEcCtD
Docetaxel—TUBB—uterus—polycystic ovary syndrome	0.0004	0.00649	CbGeAlD
Docetaxel—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000398	0.0113	CcSEcCtD
Docetaxel—TUBB2A—uterus—polycystic ovary syndrome	0.000398	0.00646	CbGeAlD
Docetaxel—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000394	0.0112	CcSEcCtD
Docetaxel—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000393	0.0111	CcSEcCtD
Docetaxel—TUBB—pituitary gland—polycystic ovary syndrome	0.000393	0.00638	CbGeAlD
Docetaxel—TUBB6—uterus—polycystic ovary syndrome	0.000392	0.00637	CbGeAlD
Docetaxel—TUBB—adipose tissue—polycystic ovary syndrome	0.000391	0.00635	CbGeAlD
Docetaxel—TUBB2A—pituitary gland—polycystic ovary syndrome	0.000391	0.00634	CbGeAlD
Docetaxel—TUBB2A—adipose tissue—polycystic ovary syndrome	0.000389	0.00632	CbGeAlD
Docetaxel—TUBB6—pituitary gland—polycystic ovary syndrome	0.000385	0.00625	CbGeAlD
Docetaxel—TUBB6—adipose tissue—polycystic ovary syndrome	0.000384	0.00623	CbGeAlD
Docetaxel—TUBB4A—adrenal gland—polycystic ovary syndrome	0.000384	0.00623	CbGeAlD
Docetaxel—Eye disorder—Metformin—polycystic ovary syndrome	0.000374	0.0106	CcSEcCtD
Docetaxel—ABCC10—endometrium—polycystic ovary syndrome	0.000373	0.00605	CbGeAlD
Docetaxel—SLC22A7—endocrine gland—polycystic ovary syndrome	0.000372	0.00604	CbGeAlD
Docetaxel—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000371	0.0105	CcSEcCtD
Docetaxel—Flushing—Metformin—polycystic ovary syndrome	0.000371	0.0105	CcSEcCtD
Docetaxel—TUBB2B—adrenal gland—polycystic ovary syndrome	0.000371	0.00602	CbGeAlD
Docetaxel—TUBB4B—endometrium—polycystic ovary syndrome	0.00037	0.00601	CbGeAlD
Docetaxel—Angiopathy—Metformin—polycystic ovary syndrome	0.000363	0.0103	CcSEcCtD
Docetaxel—Immune system disorder—Metformin—polycystic ovary syndrome	0.000361	0.0102	CcSEcCtD
Docetaxel—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000361	0.0102	CcSEcCtD
Docetaxel—Chills—Metformin—polycystic ovary syndrome	0.000359	0.0102	CcSEcCtD
Docetaxel—TUBB4A—female gonad—polycystic ovary syndrome	0.000358	0.00581	CbGeAlD
Docetaxel—TUBB—adrenal gland—polycystic ovary syndrome	0.000351	0.0057	CbGeAlD
Docetaxel—TUBB2A—adrenal gland—polycystic ovary syndrome	0.000349	0.00567	CbGeAlD
Docetaxel—Malnutrition—Metformin—polycystic ovary syndrome	0.000348	0.00986	CcSEcCtD
Docetaxel—Erythema—Metformin—polycystic ovary syndrome	0.000348	0.00986	CcSEcCtD
Docetaxel—TUBB2B—female gonad—polycystic ovary syndrome	0.000346	0.00561	CbGeAlD
Docetaxel—TUBB6—adrenal gland—polycystic ovary syndrome	0.000344	0.00559	CbGeAlD
Docetaxel—TUBB2B—vagina—polycystic ovary syndrome	0.000344	0.00558	CbGeAlD
Docetaxel—ABCC10—uterus—polycystic ovary syndrome	0.000344	0.00558	CbGeAlD
Docetaxel—Dysgeusia—Metformin—polycystic ovary syndrome	0.000341	0.00966	CcSEcCtD
Docetaxel—TUBB4B—uterus—polycystic ovary syndrome	0.000341	0.00554	CbGeAlD
Docetaxel—ABCC10—pituitary gland—polycystic ovary syndrome	0.000337	0.00548	CbGeAlD
Docetaxel—ABCC10—adipose tissue—polycystic ovary syndrome	0.000336	0.00545	CbGeAlD
Docetaxel—TUBB4B—pituitary gland—polycystic ovary syndrome	0.000335	0.00544	CbGeAlD
Docetaxel—Muscle spasms—Metformin—polycystic ovary syndrome	0.000335	0.00948	CcSEcCtD
Docetaxel—TUBB4B—adipose tissue—polycystic ovary syndrome	0.000334	0.00541	CbGeAlD
Docetaxel—TUBB4A—endocrine gland—polycystic ovary syndrome	0.000333	0.0054	CbGeAlD
Docetaxel—TUBB—female gonad—polycystic ovary syndrome	0.000327	0.00531	CbGeAlD
Docetaxel—TUBB2A—female gonad—polycystic ovary syndrome	0.000325	0.00528	CbGeAlD
Docetaxel—TUBB—vagina—polycystic ovary syndrome	0.000325	0.00528	CbGeAlD
Docetaxel—TUBB2A—vagina—polycystic ovary syndrome	0.000323	0.00525	CbGeAlD
Docetaxel—TUBB2B—endocrine gland—polycystic ovary syndrome	0.000322	0.00522	CbGeAlD
Docetaxel—TUBB6—female gonad—polycystic ovary syndrome	0.000321	0.00521	CbGeAlD
Docetaxel—TUBB6—vagina—polycystic ovary syndrome	0.000319	0.00518	CbGeAlD
Docetaxel—Syncope—Metformin—polycystic ovary syndrome	0.000312	0.00884	CcSEcCtD
Docetaxel—Palpitations—Metformin—polycystic ovary syndrome	0.000308	0.00871	CcSEcCtD
Docetaxel—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000306	0.00867	CcSEcCtD
Docetaxel—TUBB2A—endocrine gland—polycystic ovary syndrome	0.000303	0.00491	CbGeAlD
Docetaxel—ABCC10—adrenal gland—polycystic ovary syndrome	0.000301	0.00489	CbGeAlD
Docetaxel—Hypertension—Metformin—polycystic ovary syndrome	0.000301	0.00851	CcSEcCtD
Docetaxel—TUBB4B—adrenal gland—polycystic ovary syndrome	0.000299	0.00486	CbGeAlD
Docetaxel—TUBB6—endocrine gland—polycystic ovary syndrome	0.000299	0.00485	CbGeAlD
Docetaxel—Myalgia—Metformin—polycystic ovary syndrome	0.000297	0.00839	CcSEcCtD
Docetaxel—Chest pain—Metformin—polycystic ovary syndrome	0.000297	0.00839	CcSEcCtD
Docetaxel—ABCC1—adrenal cortex—polycystic ovary syndrome	0.000295	0.00479	CbGeAlD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000295	0.00834	CcSEcCtD
Docetaxel—Oedema—Metformin—polycystic ovary syndrome	0.000284	0.00805	CcSEcCtD
Docetaxel—Infection—Metformin—polycystic ovary syndrome	0.000282	0.00799	CcSEcCtD
Docetaxel—ABCC10—female gonad—polycystic ovary syndrome	0.000281	0.00456	CbGeAlD
Docetaxel—Shock—Metformin—polycystic ovary syndrome	0.00028	0.00792	CcSEcCtD
Docetaxel—ABCC10—vagina—polycystic ovary syndrome	0.000279	0.00453	CbGeAlD
Docetaxel—TUBB4B—female gonad—polycystic ovary syndrome	0.000279	0.00453	CbGeAlD
Docetaxel—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000279	0.00789	CcSEcCtD
Docetaxel—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000278	0.00788	CcSEcCtD
Docetaxel—TUBB4B—vagina—polycystic ovary syndrome	0.000277	0.0045	CbGeAlD
Docetaxel—Skin disorder—Metformin—polycystic ovary syndrome	0.000276	0.00782	CcSEcCtD
Docetaxel—Anorexia—Metformin—polycystic ovary syndrome	0.000271	0.00767	CcSEcCtD
Docetaxel—CYP1B1—uterus—polycystic ovary syndrome	0.00027	0.00439	CbGeAlD
Docetaxel—Hypotension—Metformin—polycystic ovary syndrome	0.000266	0.00752	CcSEcCtD
Docetaxel—CYP1B1—pituitary gland—polycystic ovary syndrome	0.000265	0.00431	CbGeAlD
Docetaxel—CYP1B1—adipose tissue—polycystic ovary syndrome	0.000264	0.00429	CbGeAlD
Docetaxel—ABCC1—endometrium—polycystic ovary syndrome	0.000264	0.00428	CbGeAlD
Docetaxel—ABCC10—endocrine gland—polycystic ovary syndrome	0.000261	0.00424	CbGeAlD
Docetaxel—TUBB4B—endocrine gland—polycystic ovary syndrome	0.000259	0.00421	CbGeAlD
Docetaxel—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000259	0.00733	CcSEcCtD
Docetaxel—Paraesthesia—Metformin—polycystic ovary syndrome	0.000255	0.00723	CcSEcCtD
Docetaxel—Dyspnoea—Metformin—polycystic ovary syndrome	0.000253	0.00717	CcSEcCtD
Docetaxel—Somnolence—Metformin—polycystic ovary syndrome	0.000253	0.00715	CcSEcCtD
Docetaxel—Dyspepsia—Metformin—polycystic ovary syndrome	0.00025	0.00708	CcSEcCtD
Docetaxel—Decreased appetite—Metformin—polycystic ovary syndrome	0.000247	0.007	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000245	0.00695	CcSEcCtD
Docetaxel—Fatigue—Metformin—polycystic ovary syndrome	0.000245	0.00694	CcSEcCtD
Docetaxel—ABCG2—adrenal cortex—polycystic ovary syndrome	0.000245	0.00397	CbGeAlD
Docetaxel—Constipation—Metformin—polycystic ovary syndrome	0.000243	0.00688	CcSEcCtD
Docetaxel—ABCC1—uterus—polycystic ovary syndrome	0.000243	0.00394	CbGeAlD
Docetaxel—ABCC2—adrenal gland—polycystic ovary syndrome	0.000242	0.00393	CbGeAlD
Docetaxel—ABCC1—pituitary gland—polycystic ovary syndrome	0.000239	0.00387	CbGeAlD
Docetaxel—ABCC1—adipose tissue—polycystic ovary syndrome	0.000238	0.00386	CbGeAlD
Docetaxel—CYP1B1—adrenal gland—polycystic ovary syndrome	0.000237	0.00385	CbGeAlD
Docetaxel—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000234	0.00663	CcSEcCtD
Docetaxel—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000232	0.00658	CcSEcCtD
Docetaxel—Abdominal pain—Metformin—polycystic ovary syndrome	0.000225	0.00636	CcSEcCtD
Docetaxel—CYP1B1—female gonad—polycystic ovary syndrome	0.000221	0.00359	CbGeAlD
Docetaxel—ABCG2—endometrium—polycystic ovary syndrome	0.000218	0.00354	CbGeAlD
Docetaxel—ABCC1—adrenal gland—polycystic ovary syndrome	0.000213	0.00346	CbGeAlD
Docetaxel—ABCC2—endocrine gland—polycystic ovary syndrome	0.00021	0.00341	CbGeAlD
Docetaxel—CYP1B1—endocrine gland—polycystic ovary syndrome	0.000206	0.00334	CbGeAlD
Docetaxel—Asthenia—Metformin—polycystic ovary syndrome	0.000204	0.00577	CcSEcCtD
Docetaxel—ABCG2—uterus—polycystic ovary syndrome	0.000201	0.00327	CbGeAlD
Docetaxel—Pruritus—Metformin—polycystic ovary syndrome	0.000201	0.00569	CcSEcCtD
Docetaxel—ABCC1—female gonad—polycystic ovary syndrome	0.000199	0.00323	CbGeAlD
Docetaxel—ABCC1—vagina—polycystic ovary syndrome	0.000198	0.00321	CbGeAlD
Docetaxel—ABCG2—pituitary gland—polycystic ovary syndrome	0.000198	0.00321	CbGeAlD
Docetaxel—ABCG2—adipose tissue—polycystic ovary syndrome	0.000197	0.00319	CbGeAlD
Docetaxel—Diarrhoea—Metformin—polycystic ovary syndrome	0.000195	0.00551	CcSEcCtD
Docetaxel—Dizziness—Metformin—polycystic ovary syndrome	0.000188	0.00532	CcSEcCtD
Docetaxel—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000183	0.00296	CbGeAlD
Docetaxel—Vomiting—Metformin—polycystic ovary syndrome	0.000181	0.00512	CcSEcCtD
Docetaxel—Rash—Metformin—polycystic ovary syndrome	0.000179	0.00507	CcSEcCtD
Docetaxel—Dermatitis—Metformin—polycystic ovary syndrome	0.000179	0.00507	CcSEcCtD
Docetaxel—Headache—Metformin—polycystic ovary syndrome	0.000178	0.00504	CcSEcCtD
Docetaxel—ABCG2—adrenal gland—polycystic ovary syndrome	0.000176	0.00286	CbGeAlD
Docetaxel—Nausea—Metformin—polycystic ovary syndrome	0.000169	0.00478	CcSEcCtD
Docetaxel—ABCG2—female gonad—polycystic ovary syndrome	0.000165	0.00267	CbGeAlD
Docetaxel—ABCG2—vagina—polycystic ovary syndrome	0.000164	0.00265	CbGeAlD
Docetaxel—CYP3A5—female gonad—polycystic ovary syndrome	0.000153	0.00248	CbGeAlD
Docetaxel—CYP3A5—vagina—polycystic ovary syndrome	0.000152	0.00246	CbGeAlD
Docetaxel—ABCB1—embryo—polycystic ovary syndrome	0.000147	0.00239	CbGeAlD
Docetaxel—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000142	0.00231	CbGeAlD
Docetaxel—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000121	0.00196	CbGeAlD
Docetaxel—ABCB1—endometrium—polycystic ovary syndrome	0.000108	0.00175	CbGeAlD
Docetaxel—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000107	0.00173	CbGeAlD
Docetaxel—ABCB1—uterus—polycystic ovary syndrome	9.92e-05	0.00161	CbGeAlD
Docetaxel—ABCB1—pituitary gland—polycystic ovary syndrome	9.74e-05	0.00158	CbGeAlD
Docetaxel—ABCB1—adipose tissue—polycystic ovary syndrome	9.7e-05	0.00157	CbGeAlD
Docetaxel—ABCB1—adrenal gland—polycystic ovary syndrome	8.7e-05	0.00141	CbGeAlD
Docetaxel—ABCB1—female gonad—polycystic ovary syndrome	8.12e-05	0.00132	CbGeAlD
Docetaxel—ABCB1—vagina—polycystic ovary syndrome	8.07e-05	0.00131	CbGeAlD
Docetaxel—ABCB1—endocrine gland—polycystic ovary syndrome	7.55e-05	0.00122	CbGeAlD
Docetaxel—EGFR—Signaling by PDGF—IL6—polycystic ovary syndrome	6.78e-06	8.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT2—polycystic ovary syndrome	6.75e-06	8.39e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.74e-06	8.38e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	6.71e-06	8.35e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CYP11A1—polycystic ovary syndrome	6.7e-06	8.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GNRH1—polycystic ovary syndrome	6.69e-06	8.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ATF1—polycystic ovary syndrome	6.66e-06	8.29e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SULT2A1—polycystic ovary syndrome	6.65e-06	8.27e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.65e-06	8.27e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	6.6e-06	8.2e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—NAMPT—polycystic ovary syndrome	6.56e-06	8.16e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.52e-06	8.11e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP11A1—polycystic ovary syndrome	6.48e-06	8.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	6.48e-06	8.05e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	6.44e-06	8.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IRS1—polycystic ovary syndrome	6.44e-06	8e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.43e-06	8e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SCT—polycystic ovary syndrome	6.41e-06	7.97e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	6.39e-06	7.94e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TCF7L2—polycystic ovary syndrome	6.37e-06	7.92e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	6.36e-06	7.91e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IRS1—polycystic ovary syndrome	6.34e-06	7.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—ADRB2—polycystic ovary syndrome	6.33e-06	7.87e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKR1C3—polycystic ovary syndrome	6.33e-06	7.87e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	6.29e-06	7.82e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	6.26e-06	7.79e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SLC2A4—polycystic ovary syndrome	6.26e-06	7.78e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CYP17A1—polycystic ovary syndrome	6.23e-06	7.74e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GNAS—polycystic ovary syndrome	6.22e-06	7.74e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	6.21e-06	7.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—IRS1—polycystic ovary syndrome	6.18e-06	7.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—VEGFA—polycystic ovary syndrome	6.18e-06	7.68e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	6.16e-06	7.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TAB1—polycystic ovary syndrome	6.15e-06	7.65e-05	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	6.14e-06	7.63e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKR1C3—polycystic ovary syndrome	6.12e-06	7.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	6.12e-06	7.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PRL—polycystic ovary syndrome	6.1e-06	7.58e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP17A1—polycystic ovary syndrome	6.02e-06	7.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGF18—polycystic ovary syndrome	6.01e-06	7.47e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	6e-06	7.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TCF7L2—polycystic ovary syndrome	6e-06	7.46e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	5.99e-06	7.45e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PRL—polycystic ovary syndrome	5.97e-06	7.42e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	5.97e-06	7.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RBP4—polycystic ovary syndrome	5.96e-06	7.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT2—polycystic ovary syndrome	5.96e-06	7.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	5.93e-06	7.38e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—NCOR1—polycystic ovary syndrome	5.93e-06	7.37e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	5.92e-06	7.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SLC2A4—polycystic ovary syndrome	5.9e-06	7.33e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	5.89e-06	7.33e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	5.89e-06	7.32e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT2—polycystic ovary syndrome	5.87e-06	7.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—GNAS—polycystic ovary syndrome	5.87e-06	7.3e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	5.84e-06	7.26e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.82e-06	7.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT2—polycystic ovary syndrome	5.72e-06	7.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PRL—polycystic ovary syndrome	5.63e-06	7e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CYP1A1—polycystic ovary syndrome	5.62e-06	6.99e-05	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL6—polycystic ovary syndrome	5.58e-06	6.94e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	5.58e-06	6.94e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	5.57e-06	6.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—YAP1—polycystic ovary syndrome	5.56e-06	6.92e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	5.52e-06	6.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GAB1—polycystic ovary syndrome	5.49e-06	6.82e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	5.48e-06	6.81e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	5.48e-06	6.81e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	5.48e-06	6.81e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	5.47e-06	6.8e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	5.43e-06	6.75e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TH—polycystic ovary syndrome	5.39e-06	6.7e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	5.35e-06	6.65e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—STAR—polycystic ovary syndrome	5.33e-06	6.62e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.32e-06	6.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—INSR—polycystic ovary syndrome	5.25e-06	6.52e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	5.24e-06	6.52e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—MTHFR—polycystic ovary syndrome	5.24e-06	6.51e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TH—polycystic ovary syndrome	5.21e-06	6.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—BCL2—polycystic ovary syndrome	5.2e-06	6.47e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	5.18e-06	6.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL18—polycystic ovary syndrome	5.13e-06	6.38e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	5.09e-06	6.33e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	5.08e-06	6.31e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—SLC2A4—polycystic ovary syndrome	5.07e-06	6.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRG1—polycystic ovary syndrome	5.01e-06	6.23e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NCOR1—polycystic ovary syndrome	5e-06	6.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.99e-06	6.2e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	4.93e-06	6.13e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRG1—polycystic ovary syndrome	4.91e-06	6.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.91e-06	6.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PGR—polycystic ovary syndrome	4.86e-06	6.04e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	4.77e-06	5.93e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP19A1—polycystic ovary syndrome	4.77e-06	5.93e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	4.76e-06	5.92e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	4.75e-06	5.9e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TH—polycystic ovary syndrome	4.74e-06	5.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—IL6—polycystic ovary syndrome	4.72e-06	5.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NCOR1—polycystic ovary syndrome	4.72e-06	5.86e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TH—polycystic ovary syndrome	4.7e-06	5.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRG1—polycystic ovary syndrome	4.63e-06	5.76e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	4.62e-06	5.74e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	4.61e-06	5.73e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	4.57e-06	5.68e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IL6—polycystic ovary syndrome	4.56e-06	5.66e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	4.53e-06	5.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GHRL—polycystic ovary syndrome	4.52e-06	5.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PLAT—polycystic ovary syndrome	4.52e-06	5.62e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.47e-06	5.56e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	4.45e-06	5.53e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MTHFR—polycystic ovary syndrome	4.42e-06	5.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—polycystic ovary syndrome	4.41e-06	5.48e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	4.4e-06	5.47e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	4.34e-06	5.39e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	4.33e-06	5.38e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	4.33e-06	5.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ATF1—polycystic ovary syndrome	4.31e-06	5.36e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	4.3e-06	5.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IRS2—polycystic ovary syndrome	4.29e-06	5.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CRP—polycystic ovary syndrome	4.29e-06	5.34e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	4.28e-06	5.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—IL6—polycystic ovary syndrome	4.27e-06	5.31e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GNAS—polycystic ovary syndrome	4.25e-06	5.29e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PPARG—polycystic ovary syndrome	4.25e-06	5.28e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	4.22e-06	5.25e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IRS2—polycystic ovary syndrome	4.21e-06	5.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.2e-06	5.22e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	4.19e-06	5.21e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—POMC—polycystic ovary syndrome	4.19e-06	5.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MTHFR—polycystic ovary syndrome	4.17e-06	5.18e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—INS—polycystic ovary syndrome	4.17e-06	5.18e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—LHB—polycystic ovary syndrome	4.13e-06	5.13e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—NCOR1—polycystic ovary syndrome	4.05e-06	5.04e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	4.04e-06	5.02e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	3.99e-06	4.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NGFR—polycystic ovary syndrome	3.98e-06	4.94e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	3.97e-06	4.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IRS2—polycystic ovary syndrome	3.96e-06	4.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—POMC—polycystic ovary syndrome	3.95e-06	4.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PRL—polycystic ovary syndrome	3.94e-06	4.9e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	3.93e-06	4.88e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	3.91e-06	4.86e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	3.87e-06	4.81e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP1A1—polycystic ovary syndrome	3.84e-06	4.78e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	3.84e-06	4.77e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.8e-06	4.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IRS1—polycystic ovary syndrome	3.75e-06	4.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.74e-06	4.65e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	3.7e-06	4.6e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	3.69e-06	4.58e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IRS1—polycystic ovary syndrome	3.67e-06	4.57e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	3.65e-06	4.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	3.63e-06	4.51e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	3.6e-06	4.47e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—MTHFR—polycystic ovary syndrome	3.58e-06	4.45e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—INS—polycystic ovary syndrome	3.52e-06	4.37e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	3.5e-06	4.35e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	3.48e-06	4.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT2—polycystic ovary syndrome	3.47e-06	4.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GNAS—polycystic ovary syndrome	3.47e-06	4.31e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	3.46e-06	4.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IRS1—polycystic ovary syndrome	3.46e-06	4.3e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	3.44e-06	4.28e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT2—polycystic ovary syndrome	3.4e-06	4.23e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TH—polycystic ovary syndrome	3.4e-06	4.22e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	3.36e-06	4.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—INS—polycystic ovary syndrome	3.31e-06	4.12e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	3.3e-06	4.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.3e-06	4.11e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	3.28e-06	4.08e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	3.26e-06	4.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRG1—polycystic ovary syndrome	3.24e-06	4.03e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	3.23e-06	4.02e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	3.23e-06	4.02e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	3.23e-06	4.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT2—polycystic ovary syndrome	3.2e-06	3.98e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	3.19e-06	3.96e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	3.11e-06	3.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—polycystic ovary syndrome	3.05e-06	3.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SERPINE1—polycystic ovary syndrome	3.04e-06	3.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BCL2—polycystic ovary syndrome	3.03e-06	3.77e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	3.01e-06	3.74e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	3e-06	3.73e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	2.96e-06	3.68e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—POMC—polycystic ovary syndrome	2.96e-06	3.68e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—INS—polycystic ovary syndrome	2.95e-06	3.66e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.92e-06	3.64e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARG—polycystic ovary syndrome	2.9e-06	3.61e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—POMC—polycystic ovary syndrome	2.86e-06	3.56e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—INS—polycystic ovary syndrome	2.85e-06	3.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	2.79e-06	3.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IRS2—polycystic ovary syndrome	2.78e-06	3.45e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	2.77e-06	3.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—LEP—polycystic ovary syndrome	2.72e-06	3.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—polycystic ovary syndrome	2.69e-06	3.35e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—polycystic ovary syndrome	2.65e-06	3.3e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	2.64e-06	3.29e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	2.64e-06	3.28e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	2.62e-06	3.26e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—POMC—polycystic ovary syndrome	2.61e-06	3.24e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—INS—polycystic ovary syndrome	2.59e-06	3.22e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	2.58e-06	3.21e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—INS—polycystic ovary syndrome	2.57e-06	3.19e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TH—polycystic ovary syndrome	2.56e-06	3.19e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	2.54e-06	3.16e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	2.5e-06	3.11e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	2.49e-06	3.1e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	2.49e-06	3.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IRS1—polycystic ovary syndrome	2.42e-06	3.01e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	2.41e-06	2.99e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	2.34e-06	2.92e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	2.33e-06	2.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—POMC—polycystic ovary syndrome	2.33e-06	2.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—INS—polycystic ovary syndrome	2.32e-06	2.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF1—polycystic ovary syndrome	2.25e-06	2.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT2—polycystic ovary syndrome	2.24e-06	2.79e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.22e-06	2.76e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.15e-06	2.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.13e-06	2.65e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.09e-06	2.6e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.07e-06	2.57e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.99e-06	2.48e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.99e-06	2.47e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.96e-06	2.44e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	1.89e-06	2.35e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.89e-06	2.35e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	1.87e-06	2.32e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—INS—polycystic ovary syndrome	1.86e-06	2.31e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.85e-06	2.31e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.83e-06	2.27e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.76e-06	2.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—polycystic ovary syndrome	1.72e-06	2.13e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.58e-06	1.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—polycystic ovary syndrome	1.57e-06	1.95e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—polycystic ovary syndrome	1.54e-06	1.91e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.54e-06	1.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.47e-06	1.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—polycystic ovary syndrome	1.45e-06	1.8e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.44e-06	1.8e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.43e-06	1.78e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.41e-06	1.75e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.4e-06	1.74e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.29e-06	1.6e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.23e-06	1.53e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.16e-06	1.45e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.09e-06	1.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—polycystic ovary syndrome	1.01e-06	1.26e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	8.8e-07	1.09e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	8.68e-07	1.08e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—INS—polycystic ovary syndrome	8.63e-07	1.07e-05	CbGpPWpGaD
